Oncology podcasts

Medical physicist Nick Zacharopoulos, chief executive of Aktina Medical, talks with Tami Freeman about developing radiation-oncology technologies and combining industry with academic research. He traces a career that began building radiotherapy components with his father, discusses product development at Aktina, and explains how persistence and a conversation with a colleague led him to a doctorate at McGill University.

Hosted by Tami Freeman

Chris Smith presents a science-news episode examining how artificial intelligence could be misused to develop biological weapons and how researchers and regulators are responding. The programme also covers long-lasting genetic scars after childhood chemotherapy, ultra-strong ice as a possible construction material, and methods for tracking weather patterns on distant planets.

Hosted by Chris Smith

The Chemistry World team examines research on CAR-T immunotherapy for bladder tumours, including results in mice and the challenges of treating solid cancers. A second discussion considers how incorrectly assigned spectral features may have affected interpretations of defects in carbon materials.

Hosted by Mariana Kneppers

Nature reporters discuss Dolly Parton's advocacy for vaccines and public health alongside promising phase III results for a personalised mRNA cancer vaccine for melanoma.

The hosts discuss research linking bacterial signatures to colon-cancer recurrence and a separate study of bacteriophage-derived proteins that trigger bacterial pilus detachment. The episode works through the scientific papers and experimental questions; the cancer findings concern an association rather than proof of causation.

Hosted by Vincent Racaniello, Michael Schmidt

Franziska Michor explains how evolutionary dynamics, statistics and mathematical models can inform cancer treatment. The conversation examines ways to optimize treatment choices, combinations and timing while accounting for tumour complexity and the continual evolution of cancer cells.

Hosted by Steven Strogatz

Jarle Breivik discusses cancer as a biological process and critically examines expectations of a universal cure. Conversation in Norwegian.